The Vanguard Group 13D and 13G filings for Lyell Immunopharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-12 4:04 pm Unchanged |
2024-09-30 | 13G | Lyell Immunopharma, Inc. LYEL |
The Vanguard Group | 10,071,482 3.930% |
0 (Unchanged) |
Filing |
| 2024-11-04 1:30 pm Sale |
2024-09-30 | 13G | Lyell Immunopharma, Inc. LYEL |
The Vanguard Group | 10,071,482 3.930% |
-3,532,545 (-25.97%) |
Filing |
| 2024-02-13 5:08 pm Purchase |
2023-12-29 | 13G | Lyell Immunopharma, Inc. LYEL |
The Vanguard Group | 13,604,027 5.400% |
1,012,797 (+8.04%) |
Filing |
| 2023-02-09 11:25 am Purchase |
2022-12-30 | 13G | Lyell Immunopharma, Inc. LYEL |
The Vanguard Group | 12,591,230 5.050% |
12,591,230 (New Position) |
Filing |